Evidence map›Paper›PMID 42583258›Full record

ArticleInfection and drug resistance2026

Genomic Epidemiology and Plasmid-Mediated Dissemination of Carbapenem-Resistant

Huan Zhang, Ying Wang, Caiping Mao, Wei Cui, Fangfang Fan, Yi Jiang, Jing Han

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Huan Zhang *Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, People's Republic of China.
Ying Wang *The School of Public Health, Shanxi Medical University, Taiyuan, People's Republic of China.ORCID 0009-0009-5570-9192
Caiping MaoZhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, People's Republic of China.
Wei CuiZhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, People's Republic of China.
Fangfang FanNHC Key Laboratory of Pneumoconiosis, Shanxi Key Laboratory of Chronic Respiratory Diseases and Pneumoconiosis, The First Hospital of Shanxi Medical University, Taiyuan, People's Republic of China.ORCID 0000-0002-5215-7507
Yi JiangNHC Key Laboratory of Pneumoconiosis, Shanxi Key Laboratory of Chronic Respiratory Diseases and Pneumoconiosis, The First Hospital of Shanxi Medical University, Taiyuan, People's Republic of China.
Jing HanZhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, People's Republic of China.ORCID 0009-0005-1980-3385

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Carbapenem-resistant Methods: Twenty Results: The isolates were mainly recovered from sputum and peritoneal drainage fluid, each accounting for 25% (5/20). Most isolates originated from the Surgery department (60%, 12/20), followed by the ICU (20%, 4/20). ST11 was the predominant clone (65%, 13/20), followed by ST15 (10%, 2/20), with ST638, ST1049, ST4573, ST23, and ST3332 detected at low frequencies. Thirteen isolates carried Conclusion: This study describes CRKP dissemination outside ICUs in this single tertiary hospital, driven by both ST11 clonal expansion and plasmid-mediated horizontal gene transfer. The rare

Indexed as

CRKPplasmid structurewhole-genome sequencing

Identifiers

PMID42583258
PMCPMC13460082

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.